Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Gains from Sales and Divestitures: 2022

Historic Gains from Sales and Divestitures for Agilon Health (AGL) over the last 1 years, with FY2022 value amounting to $404000.0.

  • Agilon Health's Gains from Sales and Divestitures changed N/A to $404000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $404000.0, marking a year-over-year change of. This contributed to the annual value of $404000.0 for FY2022, which is N/A changed from last year.
  • Latest data reveals that Agilon Health reported Gains from Sales and Divestitures of $404000.0 as of FY2022.
  • In the past 5 years, Agilon Health's Gains from Sales and Divestitures registered a high of $404000.0 during FY2022, and its lowest value of $404000.0 during FY2022.